P688: ASC2ESCALATE: A US PHASE 2, OPEN-LABEL, SINGLE-ARM, DOSE-ESCALATION STUDY OF ASCIMINIB MONOTHERAPY IN 2ND-LINE (2L) TREATMENT OF PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)

Bibliographic Details
Main Authors:	Ehab Atallah, Michael Mauro, Koji Sasaki, Moshe Yair Levy, Paul Koller, Islam Sadek, Daisy Yang, Julie Ruckel-Kumar, Mahmudul Khan, Jorge Cortes
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000969656.81442.84

Internet